N Nabavi

3.1k total citations · 2 hit papers
22 papers, 2.7k citations indexed

About

N Nabavi is a scholar working on Immunology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, N Nabavi has authored 22 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 6 papers in Epidemiology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in N Nabavi's work include T-cell and B-cell Immunology (9 papers), Immune Cell Function and Interaction (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). N Nabavi is often cited by papers focused on T-cell and B-cell Immunology (9 papers), Immune Cell Function and Interaction (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). N Nabavi collaborates with scholars based in United States, Switzerland and Iran. N Nabavi's co-authors include G S Gray, J A Bluestone, Deborah J. Lenschow, Laurie H. Glimcher, L H Glimcher, Sivasubramanian Baskar, Suzanne Ostrand‐Rosenberg, J W Murphy, Gordon J. Freeman and Husain Sattar and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

N Nabavi

22 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse.

1995 518 citations Deborah J. Lenschow, Shu‐Chuan Ho et al. The Journal of Experimental Medicine profile →
Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor.

1991 508 citations Ueli Gubler, A O Chua et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
N Nabavi United States	20	2.0k	510	382	377	366	22	2.7k
Nasrin Nabavi United States	12	2.1k 1.0×	494 1.0×	261 0.7×	202 0.5×	405 1.1×	13	2.8k
Rajeev R. Warrier United States	13	2.8k 1.3×	995 2.0×	503 1.3×	392 1.0×	571 1.6×	14	3.5k
P M Quinn United States	8	2.0k 1.0×	641 1.3×	327 0.9×	267 0.7×	368 1.0×	9	2.6k
Kenneth R. Youngman United States	21	1.6k 0.8×	478 0.9×	472 1.2×	603 1.6×	250 0.7×	27	2.3k
V C Maino United States	15	1.8k 0.9×	301 0.6×	498 1.3×	183 0.5×	371 1.0×	21	2.4k
A G Wolitzky United States	7	2.0k 1.0×	641 1.3×	327 0.9×	267 0.7×	364 1.0×	7	2.5k
D A Hafler United States	21	1.8k 0.9×	343 0.7×	171 0.4×	242 0.6×	296 0.8×	29	2.5k
Masayoshi Kohase Japan	23	1.3k 0.6×	461 0.9×	545 1.4×	210 0.6×	637 1.7×	51	2.4k
F W Fitch United States	24	1.9k 0.9×	346 0.7×	353 0.9×	170 0.5×	434 1.2×	41	2.7k
Guy Warnier Belgium	20	1.6k 0.8×	527 1.0×	242 0.6×	168 0.4×	461 1.3×	30	2.1k

Countries citing papers authored by N Nabavi

Since Specialization

Citations

This map shows the geographic impact of N Nabavi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N Nabavi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N Nabavi more than expected).

Fields of papers citing papers by N Nabavi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N Nabavi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N Nabavi. The network helps show where N Nabavi may publish in the future.

Co-authorship network of co-authors of N Nabavi

This figure shows the co-authorship network connecting the top 25 collaborators of N Nabavi. A scholar is included among the top collaborators of N Nabavi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N Nabavi. N Nabavi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nabavi, N, et al.. (2017). Increased Th17 functions are accompanied by Tregs activities in lupoid leishmaniasis. Parasite Immunology. 40(1). 6 indexed citations

Sahebari, Maryam, N Nabavi, & Maryam Salehi. (2014). Correlation between serum 25(OH)D values and lupus disease activity: an original article and a systematic review with meta-analysis focusing on serum VitD confounders. Lupus. 23(11). 1164–1177. 44 indexed citations

Brown, Jessica, Richard G. Titus, N Nabavi, & Laurie H. Glimcher. (1996). Blockade of CD86 Ameliorates Leishmania major Infection by Down-Regulating the Th2 Response. The Journal of Infectious Diseases. 174(6). 1303–1308. 66 indexed citations

Baskar, Sivasubramanian, Virginia K. Clements, L H Glimcher, N Nabavi, & Suzanne Ostrand‐Rosenberg. (1996). Rejection of MHC class II-transfected tumor cells requires induction of tumor-encoded B7-1 and/or B7-2 costimulatory molecules. The Journal of Immunology. 156(10). 3821–3827. 64 indexed citations

Lenschow, Deborah J., Shu‐Chuan Ho, Husain Sattar, et al.. (1995). Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse.. The Journal of Experimental Medicine. 181(3). 1145–1155. 518 indexed citations breakdown →

Baskar, Sivasubramanian, Laurie H. Glimcher, N Nabavi, Russel Jones, & Suzanne Ostrand‐Rosenberg. (1995). Major histocompatibility complex class II+B7-1+ tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice.. The Journal of Experimental Medicine. 181(2). 619–629. 162 indexed citations

Chen, Chen, et al.. (1994). Molecular cloning and expression of early T cell costimulatory molecule-1 and its characterization as B7-2 molecule.. The Journal of Immunology. 152(10). 4929–4936. 58 indexed citations

Chen, Chen, D A Faherty, Suzanne E. Connaughton, et al.. (1994). Monoclonal antibody 2D10 recognizes a novel T cell costimulatory molecule on activated murine B lymphocytes.. The Journal of Immunology. 152(5). 2105–2114. 40 indexed citations

Lenschow, Deborah J., Gloria H. Su, L Zuckerman, et al.. (1993). Expression and functional significance of an additional ligand for CTLA-4.. Proceedings of the National Academy of Sciences. 90(23). 11054–11058. 231 indexed citations

10.

Nabavi, N, et al.. (1992). Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature. 360(6401). 266–268. 255 indexed citations

11.

Hidore, M R, et al.. (1991). Murine natural killer cells are fungicidal to Cryptococcus neoformans. Infection and Immunity. 59(5). 1747–1754. 76 indexed citations

12.

Gubler, Ueli, A O Chua, David S. Schoenhaut, et al.. (1991). Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor.. Proceedings of the National Academy of Sciences. 88(10). 4143–4147. 508 indexed citations breakdown →

13.

Murphy, J W, M R Hidore, & N Nabavi. (1991). Binding interactions of murine natural killer cells with the fungal target Cryptococcus neoformans. Infection and Immunity. 59(4). 1476–1488. 34 indexed citations

14.

Grusby, Michael J., S.C. Mitchell, N Nabavi, & Laurie H. Glimcher. (1990). Casein expression in cytotoxic T lymphocytes.. Proceedings of the National Academy of Sciences. 87(17). 6897–6901. 46 indexed citations

15.

Nabavi, N, Zoher Ghogawala, I J Griffith, et al.. (1989). Antigen presentation abrogated in cells expressing truncated Ia molecules.. The Journal of Immunology. 142(5). 1444–1447. 77 indexed citations

16.

Wüthrich, Rudolf P., Mary A. Yui, Gwen Mazoujian, et al.. (1989). Enhanced MHC class II expression in renal proximal tubules precedes loss of renal function in MRL/lpr mice with lupus nephritis.. PubMed. 134(1). 45–51. 92 indexed citations

17.

Nabavi, N, et al.. (1988). Structural mutation affecting intracellular transport and cell surface expression of murine class II molecules.. The Journal of Experimental Medicine. 167(2). 541–555. 46 indexed citations

18.

Polla, Barbara S., J Ohara, W E Paul, et al.. (1988). Differential induction of class II gene expression in murine pre-B-cell lines by B-cell stimulatory factor-1 and by antibodies to B-cell surface antigens.. PubMed. 3(6). 363–73. 17 indexed citations

19.

Griffith, I J, Zoher Ghogawala, N Nabavi, et al.. (1988). Cytoplasmic domain affects membrane expression and function of an Ia molecule.. Proceedings of the National Academy of Sciences. 85(13). 4847–4851. 20 indexed citations

20.

Nabavi, N & J W Murphy. (1986). Antibody-dependent natural killer cell-mediated growth inhibition of Cryptococcus neoformans. Infection and Immunity. 51(2). 556–562. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact